Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
JAZZ
$231.52
-0.36%
JAZZ
· Jazz Pharmaceuticals plc
$231.52
-0.83 (-0.36%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$15.45B
Shares
64.91M
Volume · Sep 30
1M
Avg daily vol (3M)
862.35K
All earnings calls
Earnings call · FY2019 Q4
Jazz Pharmaceuticals plc (JAZZ) Q4 2019 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$581.74M
+22.1% YoY
Diluted EPS
$1.29
-51.1% YoY
Gross margin
93.0%
+0.4 pp YoY
Net income
$73.99M
-53.6% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Jan 14, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Apr 24, 2020 · complete as-filed document